Expand ALVO Menu
ALVO MENU

ALVO Stock Summary and Trading Ideas (Alvotech - | NASDAQ:ALVO)

Charts for Today's Stock Price and Implied Volatility in Alvotech -

11-Apr-2025

Stock Price & Volume | Full Chart

Sentiment

News

Northland Securities Keeps Their Buy Rating on Alvotech (ALVO)

TipRanks (Thu, 10-Apr 9:06 AM ET)

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer

Globe Newswire (Thu, 27-Mar 4:30 AM ET)

Alvotech Reports Record Results for 2024 and Provides Business Update

Globe Newswire (Wed, 26-Mar 6:34 PM ET)

UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair (omalizumab)

Globe Newswire (Wed, 26-Mar 4:30 AM ET)

Alvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

Globe Newswire (Thu, 20-Mar 3:00 AM ET)

Alvotech and Dr. Reddy's Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva

Business Wire (Tue, 18-Mar 8:35 AM ET)

Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva

Globe Newswire (Tue, 18-Mar 8:30 AM ET)

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Globe Newswire (Fri, 7-Mar 9:00 AM ET)

Teva and Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available in the U.S.

Globe Newswire (Fri, 21-Feb 6:00 AM ET)

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea (aflibercept)

Globe Newswire (Tue, 18-Feb 6:00 AM ET)

Trading Statistics

Key Ratios

Alvotech - (ALVO) Frequently Asked Questions

What does Alvotech - do?

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

What symbol and exchange does Alvotech - shares trade?

Alvotech - trades on the NASDAQ stock market under the symbol ALVO.

What is Alvotech - stock price doing today?

As of April 11, 2025, ALVO stock price climbed to $8.79 with 102,624 million shares trading.

What is Alvotech -'s Beta?

ALVO has a beta of 0.77, meaning it tends to be less sensitive to market movements. ALVO has a correlation of 0.11 to the broad based SPY ETF.

How much is Alvotech - worth?

ALVO has a market cap of $2.65 billion. This is considered a Mid Cap stock.

What are the top ETFs holding Alvotech -?

The top ETF exchange traded funds that ALVO belongs to (by Net Assets): IBB, IBBQ, BIB, PRFZ, STXK.

Is Alvotech - (ALVO) a good investment?

ALVO has underperformed the market in the last year with a price return of -25.8% while the SPY ETF gained +4.5%. ALVO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.0% and -8.0%, respectively, while the SPY returned -7.7% and -3.9%, respectively.

What are the support and resistance levels for Alvotech - (ALVO)?

ALVO support price is $7.89 and resistance is $8.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALVO shares will trade within this expected range on the day.